Targeting MARCO enhances cancer immunotherapy effectiveness

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

Researchers make strides in enhancing early diagnosis of bipolar disorder in adolescents

In a groundbreaking study in Biological Psychiatry, published by Elsevier, researchers report significant strides in enhancing early diagnosis of bipolar disorder in adolescents.

September 19, 2024

Low levels of ‘memory strengthening protein’ may serve as early predictor of mild cognitive impairment

Results of a long-term, federally funded study of cognitively healthy adults — most with a family history of Alzheimer’s disease — have added to evidence

July 31, 2023

Can-Fite BioPharma secures US patent for Namodenoson

The patent covers the oral administration of the drug to treat obesity. Credit: Cynthia A Jackson/Shutterstock. Can-Fite BioPharma has secured a US patent for Namodenoson,

January 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.